Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Internal Medicine
•
Neurology
What are the most significant drug interactions you consider when using cenobamate and would you ever consider using cenobamate as monotherapy?
Related Questions
How do you adjust the loading and maintenance doses for Keppra when treating status epilepticus in patients with ESRD, patients on HD, or patients on CVVH?
When do you consider ketamine to treat nonconvulsive status epilepticus?
How significant are the cardiovascular side effects, such as hypertension, associated with valproate?
If a patient who has previously been taking lamotrigine stops taking it for between two weeks and a month, do you have to uptitrate it all over again or do you have another way to resume it?
Is administration of IV or PO lacosamide, for management of status epilepticus, contraindicated in patient's with prolonged PR interval or first degree AV block on admission?
When do you consider stenting in patients with recurrent stroke with ICAD?
How do you counsel patients with epilepsy who are interested in purchasing a seizure dog?
How long do you wait for a patient to be seizure-free before you clear them with regard to operating heavy machinery (i.e., for work)?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
When do you need to keep patients on anti-seizure medications when they had an acute symptomatic seizure in the setting of eclampsia, particularly if MgSO4 was given and there was no seizure recurrence?
